Evidence map›Paper›PMID 28506144›Full record

SynthesisThe International journal of clinical and experimental hypnosis

Hypnosis for Symptom Control in Cancer Patients at the End-of-Life: A Systematic Review.

Guy H Montgomery, Madalina Sucala, Tessa Baum, Julie B Schnur

2 registry-linked trialsAbstract readSystematic Review
In one paragraph

Synthesis in The International journal of clinical and experimental hypnosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04868357 nacompletednot on this map

Efficacy of Self-administered Hypnosis for the Complementary Management of Anxiety and Dyspnea During Pulmonary Rehabilitation: A 2-armed Randomized Controlled Trial

TypeinterventionalSponsorCentre Hospitalier de BlignyRan2021 to 2024Enrolled133ConditionsCOPD, Dyspnea, AnxietyArmsHypnosis, Relaxation
NCT04999306 naterminatednot on this map

Feasibility Study of a Hypnosis Intervention and a Cognitive Behavioral Therapy Intervention to Reduce Fatigue in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

TypeinterventionalSponsorInstitut du Cancer de Montpellier - Val d'AurelleRan2023 to 2023Enrolled1ConditionsColorectal Cancer MetastaticArmsHypnosis, CBT
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Mapping a decade of interventions to address the supportive care needs of individuals living with or beyond cancer: a scoping review of reviews.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  3. Review
  4. The Role of Hypnosis in Cancer Care.Current oncology reports · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Guy H Montgomerya Icahn School of Medicine at Mount Sinai , New York , New York , USA.
Madalina Sucalaa Icahn School of Medicine at Mount Sinai , New York , New York , USA.
Tessa Bauma Icahn School of Medicine at Mount Sinai , New York , New York , USA.
Julie B Schnura Icahn School of Medicine at Mount Sinai , New York , New York , USA.
Icahn School of Medicine at Mount Sinai · US

Funding

Training providers in CBT plus Hypnosis - an evidence-based fatigue interventionR25CA193098 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MONTGOMERY, GUY H · 2015 to 2019
$1.4M
Cancer treatment retraumatization in sexual abuse survivorsR21CA173163 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHNUR, JULIE B. · 2014 to 2015
$406k
NCI NIH HHS R21 CA173163NCI NIH HHS R25 CA193098
6 · The paper itself

Abstract

Hypnosis has been shown to alleviate symptoms and side effects of cancer and its treatment. However, less is known about the use of hypnosis at the end of life in individuals with cancer. Our goal was to systematically review the literature on the use of hypnosis to manage the most common symptoms of end-of-life cancer patients: fatigue, sleep disturbances, pain, appetite loss, and dyspnea. EMBASE, MEDLINE, COCHRANE, PsychINFO, and SCOPUS databases were searched from inception through November 7, 2016. No studies met the inclusion criteria. It appears that hypnosis has never been rigorously tested as a means to ameliorate the most common symptoms in individuals with cancer at the end of their lives. This finding is troubling, as it strongly implies that a population most in need has been largely neglected. However, a clear future research direction is revealed that may have significant clinical impact.

Indexed as

HypnosisHumansNeoplasmsTerminal Care

Identifiers

PMID28506144
PMCPMC5734627
OpenAlexW2615805383

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.